Therapix Biosciences Announces Replacement of its Board of Directors

TEL AVIV, Israel, Aug. 21, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today the replacement of its board of directors. The…

About the Author

has written 37585 stories on this site.

Copyright © 2010 Business and Corporate News.